Single Technologies Company

Founded in Stockholm, Sweden, with its long tradition in fiber optics, ultra-sensitive fluorescence spectroscopy and DNA sequencing, SINGLE’s ambition is to become a leading provider of sequencing technologies for the 21st century diagnostics.

Founded Date: 2012-01-01
Technology: P4 Medicine
Investor Type: For Profit
Funding Status: Seed
Total Funding: $4.9M
Employee Number: 11-50
Headquarters: Stockholm, Stockholms Lan, Sweden
Investors Number: 1
Last Funding Type: Corporate Round
Estimated Revenue: Less than $1M
Industry: Biotechnology, Health Care, Science and Engineering